Patents Assigned to EnGeneIC Gene Therapy Pty Limited
  • Publication number: 20140220116
    Abstract: A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs bispecific ligands, comprising a first arm that carries specificity for a bacterially derived minicell surface structure and a second arm that carries specificity for a mammalian cell surface receptor, to target drug-loaded minicells to specific mammalian cells and to cause endocytosis of the minicells by the mammalian cells. Another drug delivery method exploits the natural ability of phagocytic mammalian cells to engulf minicells without the use of bispecific ligands.
    Type: Application
    Filed: April 9, 2014
    Publication date: August 7, 2014
    Applicant: EnGeneIC Gene Therapy Pty Limited
    Inventors: Himanshu Brahmbhatt, Jennifer MACDIARMID
  • Publication number: 20080051469
    Abstract: A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs bispecific ligands, comprising a first arm that carries specificity for a bacterially derived minicell surface structure and a second arm that carries specificity for a mammalian cell surface receptor, to target drug-loaded minicells to specific mammalian cells and to cause endocytosis of the minicells by the mammalian cells. Another drug delivery method exploits the natural ability of phagocytic mammalian cells to engulf minicells without the use of bispecific ligands.
    Type: Application
    Filed: January 27, 2005
    Publication date: February 28, 2008
    Applicant: EnGeneIC Gene Therapy Pty Limited
    Inventors: Himanshu Brahmbhatt, Jennifer MacDiarmid